Background-Prompt recognition of underlying cardiovascular implantable electronic device (CIED) infection in patients presenting with Staphylococcus aureus bacteremia (SAB) is critical for optimal management of these cases. 
S
taphylococcus aureus is one of the leading causes of bloodstream infection in both community and healthcare settings and is associated with significant morbidity and mortality. 1, 2 Staphylococcus aureus bacteremia (SAB) in cardiovascular implantable electronic device (CIED) recipients can be because of device infection or a separate source. 3 Patients with a non-CIED source of SAB are at risk of hematogenous seeding of CIED leads. 4 In previous publications, the reported rates of underlying CIED infection in patients presenting with SAB range from 30% to 50%. 3, 5, 6 Prompt recognition of underlying CIED infection in SAB cases is critical because antimicrobial therapy alone without expedited complete device removal is associated with high mortality and risk of relapse. In 1 study of SAB in CIED recipients, 3 patients who were managed with antimicrobial therapy alone were more likely to die (47.6%) versus those who underwent complete device extraction (16.7%). Treatment failure (death or development of relapsing SAB) in this study was 52% with conservative therapy versus 25% with device extraction.
Diagnosis of CIED infection is obvious in the large majority of patients who present with inflammatory changes (pain, erythema, swelling, and drainage) or cellulitis at the generator pocket. 7 However, a high index of suspicion is needed in patients with SAB without CIED pocket symptoms to secure the diagnosis of underlying CIED infection by obtaining transesophageal echocardiography (TEE). There is limited evidence-based guidance for clinicians to decide which patients with SAB and presence of CIED should undergo further testing with TEE and device extraction if endovascular device infection is confirmed. Previous studies addressing this issue had relatively smaller cohorts of patients, included patients with generator pocket infection, and none had a multivariable analysis to identify independent predictors of CIED infection. 3, 5 Consequently, the most recent scientific statement from the American Heart Association/Heart Rhythm Society on diagnosis and management of CIED infection 8 specifically identifies a need to define a scoring system that distinguishes patients with SAB and no other evidence of device infection who prove to have CIED infection from those who do not; so, that unnecessary device removal can be avoided. In this investigation, our goal was to identify clinical predictors of underlying CIED infection in patients presenting with SAB but no signs of pocket infection, using a multivariable logistic regression model, to enable clinicians estimate the risk of CIED infection for individual patients.
Methods
All consecutive patients diagnosed with SAB at Mayo Clinic, Rochester, from January 2001 to December 2011 were retrospectively reviewed. Cases of SAB were identified via computerized database of the microbiology laboratory at Mayo Clinic and electronic medical records. Medical records of all patients with SAB were then manually reviewed to identify patients who had a CIED (permanent pacemaker [PPM] or implantable cardioverter-defibrillator) in place at the time of SAB. Patients with clinical evidence of CIED pocket infection were excluded from this study. The Mayo Foundation Institutional Review Board approved the study protocol.
Definitions

CIED Infection
CIED infection was defined based on clinical, microbiological, and echocardiographic criteria described earlier. 5, 7, 8 Clinical evidence of CIED generator pocket infection included local signs of inflammation at the generator pocket (eg, erythema, warmth, fluctuance, wound dehiscence, tenderness, purulent drainage, or erosion of the generator leads through the skin). CIED-related infective endocarditis was confirmed if lead vegetations were detected by echocardiography or if the modified Duke criteria for infective endocarditis were met. [9] [10] [11] Only cases that met Duke criteria for definite endocarditis were classified as CIED-infective endocarditis because patients with SAB, fever, and presence of an intracardiac device would automatically be classified as Duke possible. CIED infection was microbiologically confirmed on the basis of positive culture results from the generator pocket, lead(s), or blood (in the presence of local inflammatory signs at the generator pocket). Device infection was rejected if the patient had no clinical evidence of CIED infection at the time of the initial SAB diagnosis, the device was not removed, and there was no evidence of SAB relapse within 12 weeks after discharge.
Staphylococcus aureus bacteremia
Cases SAB were classified as nosocomial, healthcare associated, or community acquired, as defined by Friedman et al.
12
Nosocomial Bacteremia
Nosocomial bacteremia was defined as positive blood culture result obtained from patients who had been hospitalized for ≥48 hours. If a patient were to be transferred from another hospital, the duration of inpatient stay was calculated from the date of the first hospital admission.
Healthcare-Associated Bacteremia
Healthcare-associated bacteremia was defined by a positive blood culture result obtained from a patient at the time of hospital admission or within 48 hours of admission if the patient fulfilled any of the following criteria: (1) received intravenous therapy at home; received wound care or specialized nursing care through a healthcare agency, family, or friends; or had self-administered intravenous medical therapy in the 30 days before bloodstream infection; patients whose only home therapy is oxygen use were excluded, (2) attended a hospital or hemodialysis clinic or received intravenous chemotherapy in the 30 days before the bloodstream infection, (3) was hospitalized in an acute care hospital for 2 days in the 90 days before the bloodstream infection, or (4) resided in a nursing home or long-term care facility.
Community-Acquired Bacteremia
Community-acquired bacteremia was defined by a positive blood culture result obtained at the time of hospital admission or within 48 hours after hospital admission for patients who did not fit the criteria for a healthcare-associated infection.
Duration of SAB
Duration of SAB was defined from the date when the initial positive blood culture was obtained to date when the first negative blood culture was obtained.
All cases of SAB or CIED infection for which classification was unclear or controversial were reviewed by an experienced investigator (M.R.S. or L.M.B.).
Statistical Methods
Continuous features were summarized with means, medians, and 25th and 75th percentiles; categorical features were summarized with counts and percentages. Associations with CIED infection were evaluated using logistic regression models and summarized with odds ratios (ORs) and 95% confidence intervals (CIs). A multivariable model was developed using stepwise selection, with the P value for a feature to enter or leave the model set to 0.05. Model discrimination (how well the features in the model separate patients with and without CIED infection) was summarized using the area under a receiver operating characteristics curve. The area under the receiver operating characteristics curve can range from 0.5 to 1.0, with higher values indicating improved predictive ability or improved discrimination. Model calibration (how well the predicted probabilities of the event estimated by the model agree with the observed event) was summarized using the Hosmer and Lemeshow goodness-of-fit test. A statistically significant P value from this test would reject the null hypothesis that the features in the model fit the data well. Analyses were performed using the SAS software package (SAS Institute, Inc,
WHAT IS KNOWN
• Staphylococcus aureus bacteremia is frequently associated with underlying cardiovascular implantable electronic device infection.
• There is limited evidence-based guidance for clinicians to decide which patients with Staphylococcus aureus bacteremia and presence of cardiovascular implantable electronic device should undergo further testing with transesophageal echocardiography and device extraction if endovascular device infection is confirmed.
WHAT THE STUDY ADDS
• Our study findings suggest that the presence of a permanent pacemaker, >1 device-related procedure, and duration of Staphylococcus aureus bacteremia ≥4 days are independent predictors of cardiovascular implantable electronic device infection in patients presenting with Staphylococcus aureus bacteremia.
• Patients who do not have any of these high-risk features and no evidence of generator pocket infection on physical examination have low risk of underlying cardiovascular implantable electronic device infection and may be managed without device extraction.
Cary, NC). All tests were 2-sided, and P values <0.05 were considered statistically significant.
Results
Study Population
We identified 131 patients with CIEDs who were hospitalized with SAB during the study period and met inclusion criteria. Seventy-seven percent of patients were men, and the median age of the patient cohort was 73 years. The majority (85%) of patients underwent echocardiography. Approximately 64% of patients underwent TEE, and 21% had transthoracic echocardiography (TTE) only. Forty-five (34.3%) of patients met the study criteria for CIED infection. All patients who were classified as having CIED infection underwent echocardiography; 91% had TEE, and 9% had only TTE. Forty-one cases of CIED infection had intracardiac vegetations on TEE. Three patients had negative TTE, but vegetations on device lead were observed on subsequent TEE. Clinical presentation, management, and outcome of the 45 patients classified as having CIED infection are summarized in Tables 1 and 2 . There was no statistically significant difference in overall survival between patients with and without CIED infection ( Figure 1 ).
Model Development
Univariate associations of host and device-related risk factors with CIED infection are summarized in Table 3 . Age at onset of SAB (OR, 0.97; 95% CI, 0.95-1.00), PPM as device type (OR, 3.77; 95% CI, 1.73-8.18), history of >1 CIED-related procedure (OR, 2.37; 95% CI, 1.03-5.45), and duration of SAB (OR, 1.28 [representing a 1-day increase in the SAB duration]; 95% CI, 1.12-1.48) were associated with increased odds of having CIED infection. Risk of CIED infection with SAB duration ≥4 days, for instance, was associated with an OR of 5.12 (95% CI, 2.30-11.40). Of note, number of CIED leads, presence of a central venous catheter, prosthetic heart valve, hemodialysis, presumed source of SAB, and onset of SAB (nosocomial versus healthcare-associated versus community-onset) were not associated with increased risk of CIED infection.
A multivariable model was developed using stepwise selection, with the P value for a feature to enter or leave the model set to 0.05. Significant associations identified in the multivariable model are summarized in Table 4 . The presence of PPM as a cardiac device (OR, 3.90; 95% CI, 1.65-9.23), history of >1 device-related procedure (OR, 3.30; 95% CI, 1.23-8.86), and SAB duration ≥4 days (OR, 5.54; 95% CI, 3.32-13.23) were independently associated with increased risk of CIED infection. The area under the receiver operating characteristics curve for this multivariable model was 0.79, and the P value from the Hosmer and Lemeshow goodness-of-fit test was 0.90, indicating that the features in the model fit the data well.
The equation derived from this logistic regression model can be used to calculate the predicted probability that a patient will experience CIED infection based on the 3 features listed above. ]=0.07). At the other end of the spectrum, if a patient has all 3 features listed above, x=1.6700, and the predicted probability of CIED infection is 84%.
Scoring System
A scoring algorithm was created using the coefficients from the multivariable logistic regression model. The coefficient for each feature was divided by the coefficient for duration of SAB ≥4 days (ie, the highest coefficient) and multiplied by a constant, in this case 5, resulting in 4 points assigned for PPM as device type, 3.5 points assigned for history of >1 device-related procedure, 5 points assigned for duration of SAB duration ≥4 days, and 0 otherwise. The calculated scores ranged from a low of 0 to a high of 12.5 (mean, 5.2; median, 5; Q1-Q3, 3.5-9). If the score is placed in a logistic regression model, each 1-U increase in the score was associated with a 41% increased odds of CIED infection (OR, 1.41; 95% CI, 1.23-1.61; P<0.001), with a c-index of 0.79.
The combinations of 3 risk factors identified in the multivariable model, the calculated risk score, and the corresponding predicted probabilities of CIED infection are summarized in Table 5 and Figure 2 .
Discussion
Our study is the first to include a multivariable analysis and a prediction model to assess the risk of underlying CIED infection in device recipients who present with SAB. Underlying CIED infection should always be a concern in device recipients who present with SAB. However, CIED infection may not be clinically evident if signs or symptoms of generator pocket infection are absent. Among our study cohort of SAB cases in CIED recipients, only 11 (19.6%) of 56 had clinical evidence of generator pocket infection (and these patients were excluded from the risk factor analysis). Undiagnosed CIED infection in SAB cases and management of bloodstream with antimicrobial therapy alone in these cases are associated with high morbidity and mortality. 3, 13 In an earlier cohort of CIED patients who presented with SAB, 3 CIED-infection related mortality was 47% if the infected device was not removed versus 16% in patients managed with complete device extraction. In this investigation, conservative management of known CIED infection cases with antimicrobial therapy alone resulted in adverse outcome (relapse or death) in 75% (9 of 12) of the cases. Therefore, prompt recognition of underlying device infection in SAB cases and expedited device removal are critical for optimal management of these cases. On the other hand, unnecessary device extraction in low-risk patients is neither advisable nor desirable. Currently, there is limited guidance 3, 5 on which patients presenting with SAB are at an increased risk of underlying device infection and should undergo expedited TEE for further diagnostic evaluation.
In our multivariable analysis, PPM as device type, >1 device-related procedure, and duration of SAB ≥4 days were independent predictors of CIED infection in SAB cases. The presence of ≥1 of these risk factors was associated with higher likelihood of underlying CIED infection. Based on the findings of our multivariable analysis, we were able to devise a prediction model and scoring system to predict the probability of CIED infection in patients presenting with SAB (Tables 4  and 5 and Figure 2 ). Only 1 patient in our study cohort had none of these high-risk features but had echocardiographic evidence of device lead infection. We think that this prediction model and the scoring system can be helpful for clinicians to risk stratify their patients presenting with SAB and make informed decision on additional testing and need for CIED extraction.
Prolonged duration of SAB has been identified as a risk factor for complicated bloodstream infection in earlier investigations. In a large prospective, observational study of 724 patients, 14 sustained SAB (positive follow-up blood culture results at 48-96 hours) was the strongest predictor (OR, 5.58; 95% CI, 3.93-7.95) of complicated SAB. Similarly, in a previous smaller study 15 of 55 patients with catheter-related SAB, sustained bacteremia beyond 3 days was associated with higher likelihood of complications (endocarditis or osteomyelitis). In our multivariable prediction model, a SAB duration ≥4 day was one of the strongest predictors of underlying CIED infection (OR, 5.54; 95% CI, 3.32-13.23). Patients with signs of pocket infection were excluded to address the question of hematogenous seeding of CIED. Among patients who present with no signs of pocket infection and SAB, the duration of bacteremia is the strongest predictor of underlying CIED infection. It is not clear why the presence of a PPM rather than implantable cardioverter-defibrillator is associated with a higher risk of CIED infection. In our analysis, the presence of prosthetic valve or hemodialysis was not associated with a higher risk of CIED infection. However, regardless of cardiac device type or host factors, prolonged SAB is associated with a higher risk of CIED infection and evaluation with TEE should be performed.
Patients who have signs and symptoms suggestive of endocarditis (such as new murmur or worsening heart murmur, conjunctival hemorrhages, or embolic lesions), those who have additional risk factors for CIED infection identified in our analysis (pacemaker as CIED type or previous history of device revisions), and those who are clinically unstable (hypotension, cardiac arrhythmia, and EKG changes) should undergo TEE soon after admission. However, for cases where the only indication for performing TEE are positive blood cultures for S. aureus, we recommend waiting until blood cultures are negative and then use the duration of SAB (>4 days or less) as a criteria for deciding whether conservative management is [16] [17] [18] [19] [20] [21] In our prediction model, patients with history of >1 device-related procedure, without any additional risk factors, had 20% predicted probability of CIED infection. Interestingly, PPM as device type was also an independent predictor of CIED infection in our multivariable analysis. The precise reasons for this association are unclear. We analyzed the time from the last device procedure to SAB, age of the patient at presentation, the number of device leads, and presence of comorbid conditions and did not find any significant differences to explain this finding.
Only 2 previous publications have explored the association between SAB and risk of CIED infection. 3, 5 First report by Chamis et al 3 included 33 patients with CIEDs and SAB for a 6-year time period. The overall incidence of CIED infection was 45.4% (15 of 33 SAB cases). In 60% of the patients (9 of 15) with confirmed device infection, patients had no local signs or symptoms, suggesting generator pocket infection. In our analysis, we excluded patients with clinical signs of pocket infection because diagnosis of CIED infection is selfevident and use of a clinical prediction tool is unnecessary.
Because of a small sample size, the report by Chamis et al 3 did not include a statistical analysis to identify risk factors associated with the development of CIED infection. The second report from our institution 5 included an earlier cohort of 62 SAB cases in CIED recipients from 2001 to 2006. Twentytwo patients (35.5%) had a diagnosis of CIED infection. The majority of CIED infection cases in this cohort were devicerelated infective endocarditis (12 of 22, 55%) . Similarly, because of smaller sample size, a multivariable analysis to identify risk factors for CIED infection in SAB cases could not be performed.
Our study has certain limitations, including selection, referral, and cases ascertainment biases primarily because of its retrospective design. We have attempted to minimize these biases by relying only on objective data, such as blood culture results, and by using a standardized (and reproducible) definition for device infection. 5, 7, 8 As the decision to obtain TEE in SAB cases and its timing were at the discretion of the attending physician, it was not possible to definitely exclude lead or valvular vegetations in all patients. Therefore, it is conceivable that we may have missed lead vegetation in few patients who did not undergo TEE testing. Therefore, it is possible, although unlikely, that prolonged antimicrobial therapy without CIED extraction may have cured some patients with unknown CIED infection. However, our rate of CIED infection in SAB cases is similar to previous investigations, and therefore, we do not think that many cases of CIED infection were missed. Although we included clinical follow-up data for 12 weeks after completion of antimicrobial therapy for SAB, patients can potentially develop relapsing bacteremia months after completion of antimicrobial course. Without long-term clinical follow-up data, it is possible that late relapses may have been missed. The presence of a mobile mass on CIED lead on echocardiography, in the setting of SAB, was used as a diagnostic criterion for CIED infection in our study. However, it is possible that some of these masses were sterile thrombi and not infected vegetations. 22 Ideally, the study sample should have been split, with 1 group of cases used to develop the prediction model and the other group to validate the model. However, because of the sample size in our cohort, this was not feasible. Risk scores: we assigned 4 points for PPM device, 3.5 points were assigned for >1 device-related procedure, 5 points were assigned for the duration of SAB ≥4 days, and 0 otherwise. CIED indicates cardiovascular implantable electronic device; ICD, implantable cardioverter-defibrillator; no of infected cases, number of patients with CIED infection in our cohort; no. of SAB cases, patients in this study with combination of features listed; PP, predicted probability of CIED infection from multivariable model; PPM, permanent pacemaker; and SAB, Staphylococcus aureus bacteremia. 
Conclusions
The presence of a PPM rather than implantable cardioverterdefibrillator, history of multiple device revisions, and SAB duration ≥4 days are independent predictors of CIED infection. Clinicians can estimate an individual patient's risk of underlying CIED infection based on the presence or absence of these risk factors. Patients who do not have any of these high-risk features and no evidence of generator pocket infection on physical examination have low risk of underlying CIED infection and may be managed without device extraction. However, prospective validation of our proposed model is necessary before it can be advocated for use in routine clinical practice. Close monitoring and follow-up are recommended in all cases to detect any relapse of SAB. Figure 2 . Risk scores and predicted probability of cardiovascular implantable electronic device infection. Four points were assigned for permanent pacemaker, 3.5 points were assigned for >1 device-related procedure, and 5 points were assigned for duration of Staphylococcus aureus bacteremia ≥4 days.
